Skip to main content
. 2019 May 18;6:2333794X19849749. doi: 10.1177/2333794X19849749

Table 2.

Univariate and Multivariate Associations of 1-Year Mortality by Childhood Cancer Diagnosis at Uganda Cancer Institute.

Characteristics Summary Statistics Non-BL NHL (N = 32)
Summary Statistics Hodgkin Disease (N = 20)
Univariate Multivariate Univariate Multivariate
HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
Age (years), median (range), per 1-year increase 8 (1-19) 0.95 (0.85-1.06) .34 11 (7-14) 1.05 (0.87-1.27) .6
Females, n (%); vs males 10 (31.3) 2.46 (0.87-7.00) .09 31.66 (1.32-759.33) .03 5 (25) 2.02 (0.36-11.23) .42
Histology, n (%) 32 (100) 20 (100)
Fever, n (%); vs no fever 24 (75.0) 10.36 (1.34-80.17) .03 9.68 (0.31-298.90) .2 11 (55.0) 1.82 (0.33-9.99) .49
Edema, n (%); vs no edema 5 (15.6) 3.12 (0.61-15.99) .17 1 (5) 5.82 (0.6-55.96) .13
Under weight for age, n (%) 4 (23.5) 3 (18.7) 4.02 (0.65-24.82) .13
HIV positive, n (%); vs HIV negative 7 (21.8) 2.04 (0.43-9.64) .37 1 (5.0)
Hb, median (IQR), per 1 g increase 8.4 (7-10.3) 0.82 (0.65-1.04) .1 9 (5.6-10.5) 0.59 (0.36-0.95) .03
Hb <8 g/dL, n(%); vs ≥8 g/dL 14 (46.7) 1.94 (0.63-5.96) .25 8 (40) 9.38 (1.09-80.66) .04 6.22 (0.68-56.82) .11
Plt <150 × 103/dL, n (%); vs ≥150 × 103/dL 20 (69.0) 2.68 (0.87-8.23) .09 4.61 (0.22-94.98) .32 15 (75) 11.68 (1.89-72.03) .01 6.82 (1.07-43.41) .04
Late stage, n (%); late vs earlya 26 (81) 3.62 (0.48-27.61) .2 1.33 (0.1-17.77) .83 10 (50.0) 1.21 (0.24-6.0) .82

Abbreviations: non-BL NHL, non-Burkitt lymphoma non-Hodgkin lymphoma; HR, hazard ratio; CI, confidence interval; HIV, Human immune deficiency virus; IQR, interquartile range; Hb, hemoglobin level; Plt, platelet count.

a

Late-stage disease (stages III and IV); early-stage disease (stages III and IV).